Earlier this month, the US President signed a landmark executive order aimed at delivering “most favored nation” (MFN) pricing for...

In clinical trials, every element of the supply chain matters. From sourcing high-quality comparator drugs to managing timelines across...

So are we! We’re pleased to share that Jonathan Miller , CSI’s Head of Operations, North America , will be attending Jefferies New York...

CSI’s Strategic Approach to Mitigating Clinical Trial Supply Disruption Recent developments in U.S. trade policy are shaking up supply...

We’re proud to share that CSI is now fully registered and qualified with  SAM.gov  and BARDA , enabling us to support U.S....

CSI attended the Global Clinical Supplies Group (GCSG) US Conference in San Antonio, Texas, April 27th-30th. The event brought together...

Exciting news! CSI will be exhibiting at GCSG Asia Pacific 2024 this week, on March 12-13 in Seoul! Visit us at Table 7 to learn how our...

CSI will be exhibiting at Booth 21 to meet  Vanessa Dekou PhD, MBA , our Managing Director, along with our Project Manager and Marketing...

We’re excited to announce that Stephan Muetze , Director of Project Management, and Yasmine Clemson , Project Management and Marketing...

Which Trends Will Shape Clinical Trial Supplies in 2025? The clinical trial supply industry is rapidly evolving. This change is driven by...

Request:  CSI was tasked with sourcing a vast quantity of Venetoclax and Azacitidine for a large pharmaceutical company's global study on...

CSI is excited to have our Managing Director Vanessa Dekou featured on the front cover of Life Sciences Magazine!  This recognition is...

Ensuring Efficiency, Compliance and Success Full supply chain management in clinical trial supply encompasses the comprehensive oversight...

This month, we are focusing on Oncology and have reflected on the notable advancements to oncology medications in recent years....

Clinical trials are the backbone of medical research, serving as a critical step in evaluating the safety and efficacy of new drugs and...

Ryvu Therapeutics Announces Entering into Agreement with Clinical Services International (CSI) in the Area of Securing Venetoclax Supply...

The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the...

Here is a success story that demonstrates how CSI can support your clinical trial supplies. CSI managed to compress six months of...